Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

"No evidence" that recovered COVID-19 patients cannot be reinfected: WHO

Published 2020-04-25, 06:20 a/m
© Reuters. FILE PHOTO: A logo is pictured on the headquarters of the WHO in Geneva

GENEVA (Reuters) - The World Health Organization (WHO) said on Saturday that there was currently "no evidence" that people who have recovered from COVID-19 and have antibodies are protected from a second coronavirus infection.

In a scientific brief, the United Nations agency warned governments against issuing "immunity passports" or "risk-free certificates" to people who have been infected as their accuracy could not be guaranteed.

The practice could actually increase the risks of continued spread as people who have recovered may ignore advice about taking standard precautions against the virus, it said.

"Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an 'immunity passport' or 'risk-free certificate' that would enable individuals to travel or to return to work assuming that they are protected against re-infection," the WHO said.

"There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection," it said.

Chile said last week it would begin handing out "health passports" to people deemed to have recovered from the illness. Once screened to determine if they have developed antibodies to make them immune to the virus, they could immediately rejoin the workforce.

The WHO said it continued to review the evidence on antibody responses to the virus, which emerged in the central Chinese city of Wuhan late last year. Some 2.8 million people have been reported to be infected by the novel coronavirus globally and 196,298 have died, according to a Reuters tally.

© Reuters. FILE PHOTO: A logo is pictured on the headquarters of the WHO in Geneva

Most studies have shown that people who have recovered from infection have antibodies to the virus, the WHO said. However, some of them have very low levels of neutralizing antibodies in their blood, "suggesting that cellular immunity may also be critical for recovery", it added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.